Table 1 Data of the everolimus trial. The treatment schedules which are used, the doses which are administered in mg, number of patients, and number of DLT are given
From: Phase I dose-escalation oncology trials with sequential multiple schedules
Schedule | Dose | Number | Number |
|---|---|---|---|
(mg) | of patients | of DLT | |
Weekly | 20.0 | 5 | 0 |
Weekly | 30.0 | 13 | 4 |
Daily | 2.5 | 4 | 2 |
Daily | 5.0 | 6 | 3 |